Reduced osmolarity oral rehydration solution for treating dehydration due to diarrhoea in children: systematic review.
OBJECTIVE
To compare reduced osmolarity oral rehydration solution with standard World Health Organization oral rehydration solution in children with acute diarrhoea.


METHODS
Systematic review of randomised controlled trials.


METHODS
15 randomised controlled trials including 2397 randomised patients.


RESULTS
The primary outcome was unscheduled intravenous infusion; secondary outcomes were stool output, vomiting, and hyponatraemia.


RESULTS
In a meta-analysis of nine trials for the primary outcome, reduced osmolarity rehydration solution was associated with fewer unscheduled intravenous infusions compared with standard WHO rehydration solution (odds ratio 0.61, 95% confidence interval 0.47 to 0.81). Three trials reported that no patients required unscheduled intravenous infusion. Trials reporting secondary outcomes suggested that in the reduced osmolarity rehydration solution group, stool output was lower (standardised mean difference in the log scale -0.214 (95% confidence interval -0.305 to -0.123; 13 trials) and vomiting was less frequent (odds ratio 0.71, 0.55 to 0.92; six trials). Six trials sought presence of hyponatraemia, with events in three studies, but no significant difference between the two arms.


CONCLUSIONS
In children admitted to hospital with dehydration associated with diarrhoea, reduced osmolarity rehydration solution is associated with reduced need for unscheduled intravenous infusions, lower stool volume, and less vomiting compared with standard WHO rehydration solution.
Hahn
S
S
Medical and Pharmaceutical Statistics Research Unit, University of Reading, Reading RG6 6FN. s.hahn@rdg.ac.uk
Kim
Y
Y
Garner
P
P
D000284:Administration, Oral; D001639:Bicarbonates / Q000627:therapeutic use; D002675:Child, Preschool; D002771:Cholera / Q000150:complications; D003681:Dehydration / Q000209:etiology / Q000628:therapy*; D003967:Diarrhea / Q000150:complications*; D005440:Fluid Therapy / Q000379:methods*; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007262:Infusions, Intravenous; D009994:Osmolar Concentration; D011189:Potassium Chloride / Q000627:therapeutic use; D015532:Rehydration Solutions / Q000737:chemistry / Q000627:therapeutic use*; D012965:Sodium Chloride / Q000627:therapeutic use; D016896:Treatment Outcome
D001639:Bicarbonates; D015532:Rehydration Solutions; C044142:World Health Organization oral rehydration solution; D012965:Sodium Chloride; D011189:Potassium Chloride; D005947:Glucose